Tatva Chintan IPO

Tatva Chintan IPO

What is an IPO?

Tatva Chintan IPO When a company or government first proposes to sell a few shares to the general public,

the process is called an initial public offering (IPO). Investors can make good money by investing in IPOs Last year, organizations raised Rs 31,000 crore from the essential market.

A total of 16 IPO launches took place, 15 of which were launched in the second half. During the full year 2019, it raised Rs 12,362 crore through 16 IPOs.

In 2018, 24 organizations raised Rs 30,959 crore through IPOs.In fact,

due to the corona virus epidemic, recovery in the domestic stock market has begun. In view of this, companies are constantly bringing in IPOs.

Abstract

When a company or government first proposes to sell certain shares to the general public,

the process is called an IPO. Today, about Tatva Chintan IPO the Rs 500 crore IPO of chemical maker Tatwa Chintan Pharma Chem opened.

In detail

Zomato’s initial public offering (IPO), which offers menus of various restaurants on its platform apart from delivery,

did not dampen investor enthusiasm. In such a situation, another company’s IPO fell on the market today. Today, the Rs 500 crore IPO of chemical maker Tatwa Chintan Pharma Chem opened. It ends July 20.

Fully subscribed in An Hour

Within 70 minutes of starting today, the IPO of the Gujarat-based chemical company was fully subscribed. Retail investors took it. The company had raised Rs 149.99 crore from 22 anchor investors before the IPO.

At the same time, Zomato’s IPO, which opened on July 14, was fully subscribed in 75 minutes.

This is the price band

The IPO price was fixed at Rs 1073-1083 per band equity share. The company has set a volume of 13 shares for the IPO. Investors must bid for at least one lot size. That means investors should invest at least Rs 13,949.

You can bid for a maximum of 14 lots, or 182 shares.

That means a maximum of Rs 1,97,106 can be invested in it.

35% share to retail investors

This includes new shares worth Rs 225 crore Existing financial backers and advertisers will sell shares worth Rs 275 crore.

35 per cent of this IPO is earmarked for retail investors.

50% is earmarked for Qualified Institutional Buyers (QIBs)

and 15% for Non-Institutional Investors (NIIs The organization’s offers are sought after in the dim market.

Its gray market premium is 690 or 64 percent higher than the issue price. Two days ago this premium was Rs.525.

Learn about Tatva Chintan Pharma

Tatva Chintan Pharma Chem was founded in 1996.

It’s anything but a substance producing organization that makes Structure Directing Agents (SDA),

Phase Transfer Catalyst (PTC), Pharma and Agrochemical Intermediates and other specific synthetic compounds.

The company will use the proceeds from the IPO to expand its Dahej unit,

develop an R&D center in Vadodara and meet the day-to-day needs of the company. The company’s customers include automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharma and other care.

Paytm to bring in Rs 16,600 crore public issue

Fintech has submitted a DRHP (application) to SEBI to raise Rs 16,600 crore from the Paytm Parent One97 Communications equity market.

While the company will raise Rs 8,300 crore by selling fresh shares through this issue, existing investors will be able to sell their shares worth Rs 8,300 crore.

It is said to be the biggest public problem in the country.

The company had a revenue of Rs 3,186 crore in the 2020-21 financial year,

compared to Rs 3,540 crore last year. The company had posted a net loss of Rs 1,701 crore in the previous fiscal.

Benefits About Tatva Chintan IPO

If pharma companies are given so many benefits in the corona era,

you know very well that you have to do it.

Philosophy Investing in pharma shares is a lucrative deal and there is going to be a rise or

fall in the shares of pharma companies in the coming period,

otherwise you can invest in this IPO without any hesitation.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: